Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
A native Canadian firm, Optimi Health Corp. (OPTI:CNX), makes synthetic formulations for transformative human experiences as well as natural, scaleable, and affordable psychedelic and functional mushrooms. The organization is included on Health Canada’s list of ... [Read]
Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
Cardinal Health (NYSE:CAH) recently announced steps to position the Company for long-term success, expanding on previously disclosed expansion goals. Elliott Investment Management L.P. (“Elliott”) provided feedback on these efforts. Elliott has also signed a collaboration ... [Read]
CytoSorbents to Present at Two Upcoming Investor Conferences
PR Newswire MONMOUTH JUNCTION, N.J. , May 19, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces ... [Read]
Calliditas Therapeutics Launches an Online Patient Platform
This launch coincides with the inaugural IgAN Awareness Day STOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) — Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the launch of IgAN Connect, a new ... [Read]
Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.31 per share a year ago. ... [Read]
Exagen Announces Five-Week Campaign for Lupus Awareness Month
SAN DIEGO, May 01, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a five-week awareness campaign to highlight important ... [Read]
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance infections. If solutions aren’t found and put in place, 10 million people could die from antibiotic resistance-related diseases by ... [Read]
Merck (MRK) Pauses Enrolment in HIV-1 Prevention Studies
Merck MRK announced that it has paused the enrolment of patients in two phase III studies, IMPOWER 22 and IMPOWER 24, which are evaluating investigational oral inhibitor, islatravir (ISL), for pre-exposure prophylaxis (PrEP) in people ... [Read]
Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval
Takeda Pharmaceutical TAK announced that the FDA has granted approval to Livtencity (maribavir) for treating post-transplant cytomegalovirus (“CMV”) infection/disease in pediatric patients aged 12 years or older and adults whose disease is refractory to treatment ... [Read]
BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500(TM)
PR Newswire BOTHELL, Wash. , Nov. 17, 2021 /PRNewswire/ — BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader ... [Read]